Related references
Note: Only part of the references are listed.Immune tolerance induction in patients with haemophilia a and inhibitors: effectiveness and cost analysis in an European Cohort (The ITER Study)
A. Rocino et al.
HAEMOPHILIA (2016)
In vivo genome editing of the albumin locus as a platform for protein replacement therapy
Rajiv Sharma et al.
BLOOD (2015)
Adeno-associated virus serotypes for gene therapeutics
Leszek Lisowski et al.
CURRENT OPINION IN PHARMACOLOGY (2015)
Comparative Study of Liver Gene Transfer With AAV Vectors Based on Natural and Engineered AAV Capsids
Lili Wang et al.
MOLECULAR THERAPY (2015)
Recurrent AAV2-related insertional mutagenesis in human hepatocellular carcinomas
Jean-Charles Nault et al.
NATURE GENETICS (2015)
Liver-directed lentiviral gene therapy in a dog model of hemophilia B
Alessio Cantore et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Naturally enveloped AAV vectors for shielding neutralizing antibodies and robust gene delivery in vivo
Bence Gyoergy et al.
BIOMATERIALS (2014)
Selection and evaluation of clinically relevant AAV variants in a xenograft liver model
Leszek Lisowski et al.
NATURE (2014)
Long-Term Safety and Efficacy of Factor IX Gene Therapy in Hemophilia B
A. C. Nathwani et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Engineered AAV vector minimizes in vivo targeting of transduced hepatocytes by capsid-specific CD8+ T cells
Ashley T. Martino et al.
BLOOD (2013)
Therapeutic levels of FVIII following a single peripheral vein administration of rAAV vector encoding a novel human factor VIII variant
Jenny McIntosh et al.
BLOOD (2013)
Prevalence and pharmacological modulation of humoral immunity to AAV vectors in gene transfer to synovial tissue
F. Mingozzi et al.
GENE THERAPY (2013)
Minimizing the Inhibitory Effect of Neutralizing Antibody for Efficient Gene Expression in the Liver With Adeno-associated Virus 8 Vectors
Jun Mimuro et al.
MOLECULAR THERAPY (2013)
A largely random AAV integration profile after LPLD gene therapy
Christine Kaeppel et al.
NATURE MEDICINE (2013)
Factor IX expression in skeletal muscle of a severe hemophilia B patient 10 years after AAV-mediated gene transfer
George Buchlis et al.
BLOOD (2012)
Hepatic Gene Transfer in Neonatal Mice by Adeno-Associated Virus Serotype 8 Vector
Lili Wang et al.
HUMAN GENE THERAPY (2012)
ACE2 and Ang-(1-7) Confer Protection Against Development of Diabetic Retinopathy
Amrisha Verma et al.
MOLECULAR THERAPY (2012)
Induction of hepatocellular carcinoma by in vivo gene targeting
Pei-Rong Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Codon optimization of human factor VIII cDNAs leads to high-level expression
Natalie J. Ward et al.
BLOOD (2011)
Systemic Errors in Quantitative Polymerase Chain Reaction Titration of Self-Complementary Adeno-Associated Viral Vectors and Improved Alternative Methods
Paolo Fagone et al.
HUMAN GENE THERAPY (2011)
A 10 Patient Case Report on the Impact of Plasmapheresis Upon Neutralizing Factors Against Adeno-associated Virus (AAV) Types 1, 2, 6, and 8
Virginie Monteilhet et al.
MOLECULAR THERAPY (2011)
In vivo genome editing restores haemostasis in a mouse model of haemophilia
Hojun Li et al.
NATURE (2011)
Adenovirus-Associated Virus Vector-Mediated Gene Transfer in Hemophilia B
Amit C. Nathwani et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Eradication of neutralizing antibodies to factor VIII in canine hemophilia A after liver gene therapy
Jonathan D. Finn et al.
BLOOD (2010)
Effect of Genome Size on AAV Vector Packaging
Zhijian Wu et al.
MOLECULAR THERAPY (2010)
X-Linked Thrombophilia with a Mutant Factor IX (Factor IX Padua)
Paolo Simioni et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Cellular immune response to cryptic epitopes during therapeutic gene transfer
Chengwen Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
AAV vector integration sites in mouse hepatocellular carcinoma
Anthony Donsante et al.
SCIENCE (2007)
CD8+ T-cell responses to adeno-associated virus capsid in humans
Federico Mingozzi et al.
NATURE MEDICINE (2007)
Effects of transient immunosuppression on adenoassociated, virus-mediated, liver-directed gene transfer in rhesus macaques and implications for human gene therapy
Haiyan Jiang et al.
BLOOD (2006)
Heparin binding directs activation of T cells against adeno-associated virus serotype 2 capsid
Luk H. Vandenberghe et al.
NATURE MEDICINE (2006)
Successful transduction of liver in hemophilia by AAV-factor IX and limitations imposed by the host immune response
CS Manno et al.
NATURE MEDICINE (2006)
PEG conjugation moderately protects adeno-associated viral vectors against antibody neutralization
GK Lee et al.
BIOTECHNOLOGY AND BIOENGINEERING (2005)
Genetic modifications of the adeno-associated virus type 2 capsid reduce the affinity and the neutralizing effects of human serum antibodies
NA Huttner et al.
GENE THERAPY (2003)
Phase 1 trial of FVIII gene transfer for severe hemophilia A using a retroviral construct administered by peripheral intravenous infusion
JS Powell et al.
BLOOD (2003)
The epidemiology of inhibitors in haemophilia A: a systematic review
J Wight et al.
HAEMOPHILIA (2003)
AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B
CS Manno et al.
BLOOD (2003)
Nonviral transfer of the gene encoding coagulation factor VIII in patients with severe hemophilia A
DA Roth et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector
MA Kay et al.
NATURE GENETICS (2000)
Share Paper
